QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.074427v1 312/1/153    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamasowa, H. Articles by Matsumura, Y. Search for Related Content PubMed PubMed Citation Articles by Yamasowa, H. Articles by Matsumura, Y.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Endothelial Nitric Oxide Contributes to the Renal Protective Effects of Ischemic Preconditioning

Department of Pharmacology, Osaka University of Pharmaceutical Science, Nasahara, Takatsuki, Osaka, Japan

We determined whether endothelial nitric oxide synthase (eNOS) plays an important role in the renal protective effect of ischemic preconditioning (IP) against the ischemia/reperfusion-induced acute renal failure (ARF) by using eNOS-deficient (eNOS^-/-) and wild-type (eNOS^+/+) mice. Ischemic ARF was induced by occlusion of the left renal artery and vein for 45 min followed by reperfusion, 2 weeks after contralateral nephrectomy. IP, which consists of three cycles of 2-min ischemia followed by 5-min reperfusion, was performed prior to 45-min ischemia. In eNOS^+/+ mice, IP treatment markedly attenuated the ischemia/reperfusion-induced renal dysfunction and significantly improved histological renal damage such as tubular necrosis, proteinaceous casts in tubuli, and medullary congestion. Constitutive nitric oxide synthase activity in the kidney without IP was markedly decreased 6 h after reperfusion, but this decreased response was not observed in eNOS^+/+ mice with IP treatment. The improvement of renal dysfunction in eNOS^+/+ mice with IP treatment was abolished by pretreatment with N^G-nitro-L-arginine, a nonselective NOS inhibitor, whereas aminoguanidine, an inducible NOS inhibitor, had no effect. Finally, no protective effects of IP on ischemia/reperfusion-induced renal dysfunction and histological damage were observed in eNOS^-/- mice. These findings strongly support the view that eNOS-mediated NO production plays a pivotal role in the protective effect of IP on ischemia/reperfusion-induced ARF.

Address correspondence to: Dr. Yasuo Matsumura, Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Nasahara, Takatsuki, Osaka, Japan. E-mail: matumrh{at}gly.oups.ac.jp

This article has been cited by other articles:

				O. Toprak, M. Cirit, M. Tanrisev, C. Yazici, O. Canoz, M. Sipahioglu, A. Uzum, R. Ersoy, and E. Y. Sozmen Preventive effect of nebivolol on contrast-induced nephropathy in rats Nephrol. Dial. Transplant., March 1, 2008; 23(3): 853 - 859. [Abstract] [Full Text] [PDF]

				J. M. Mejia-Vilet, V. Ramirez, C. Cruz, N. Uribe, G. Gamba, and N. A. Bobadilla Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone Am J Physiol Renal Physiol, July 1, 2007; 293(1): F78 - F86. [Abstract] [Full Text] [PDF]

				A. Grenz, T. Eckle, H. Zhang, D. Y. Huang, M. Wehrmann, C. Kohle, K. Unertl, H. Osswald, and H. K. Eltzschig Use of a hanging-weight system for isolated renal artery occlusion during ischemic preconditioning in mice Am J Physiol Renal Physiol, January 1, 2007; 292(1): F475 - F485. [Abstract] [Full Text] [PDF]

				A. M. G. Versteilen, I. J. M. Korstjens, R. J. P. Musters, A. B. J. Groeneveld, and P. Sipkema Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney Am J Physiol Renal Physiol, September 1, 2006; 291(3): F606 - F611. [Abstract] [Full Text] [PDF]

				M. J. Burne-Taney, M. Liu, W. M. Baldwin, L. Racusen, and H. Rabb Decreased Capacity of Immune Cells to Cause Tissue Injury Mediates Kidney Ischemic Preconditioning. J. Immunol., June 1, 2006; 176(11): 7015 - 7020. [Abstract] [Full Text] [PDF]

				A. Nakajima, K. Ueda, M. Takaoka, Y. Yoshimi, and Y. Matsumura Opposite Effects of Pre- and Postischemic Treatments with Nitric Oxide Donor on Ischemia/Reperfusion-Induced Renal Injury J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1038 - 1046. [Abstract] [Full Text] [PDF]